October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

NIH-funded Network Led by XLerateHealth and UK Supports HBCU Commercialization 

Get our GAP Insights Newsletter

Join Upcoming Events

October 18-20, 2023 / Tucson, AZ
The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

The Story

The University of Kentucky and XLerateHealth, a national startup accelerator, are partnering with Jackson State University (JSU) to launch a program that helps advance and commercialize innovative human health focused ideas from Historically Black Colleges and Universities (HBCUs). The program is receiving support from the XLerator Network, an NIH-funded accelerator hub that supports health care innovation in 24 academic institutions across the Southeastern United States.

The program, “Engaging Researchers and Innovators for Commercialization at HBCUs” (EnRICH), is spearheaded by JSU. It’s designed for faculty and student innovators at HBCUs that are located in all IDeA-eligible states, which includes 25 HBCUs.

Supported by XLerateHealth, a health care startup accelerator in Louisville, Kentucky, and by UK, the lead academic institution for the XLerator Network, EnRICH is an outgrowth of NIH funding UK received in October 2018 — $3.5 million over three years — to create the XLerator Network.

EnRICH will impact equity, diversity and inclusion in the innovation process, train HBCU faculty and students at HBCUs to critically evaluate the commercial potential of new health care innovations and support intellectual property protections for selected innovations.

“The University of Kentucky is excited for the opportunity to partner with Jackson State University and support the EnRICH program. We believe in the profound power of increasing accessibility for historically marginalized communities, and we look forward to helping improve equity in discovery and innovation,” said UK President Eli Capilouto.

EnRICH leverages the nationally recognized capabilities of UK’s Office of Technology Commercialization in protecting and commercializing intellectual property, XLerateHealth’s extensive experience with conducting biomedical technology accelerator programs, as well as the NSF I-Corps Site program at JSU. The program will provide underrepresented minorities with access to expert knowledge, entrepreneurship best practices, professional networks, mentorship, and additional resources. The goal is to expand the program to other minority-serving institutions.

“JSU is excited to lead this very important initiative, as it has great implications for creating sustainable impact on equity, diversity and inclusion in innovation and entrepreneurship,” said Thomas K. Hudson, acting president of Jackson State University.


Source: NIH-funded Network Led by XLerateHealth and UK Supports HBCU Commercialization | UKNow

Get the Report

More GAP News